SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

BioCryst Pharmaceuticals, Inc. is a biotechnology company. It engages in the provision of structure-guided drug design with the goal of developing oral small-molecule and protein therapeutics to target difficult-to-treat rare diseases. The company was founded by William M. Spencer III, Charles E. Bugg, and John A. Montgomery in 1986 and is headquartered in Durham, NC.

Biocryst Pharmaceuticals Inc.

BCRX is trending as investors discuss its potential following the Astria Therapeutics acquisition and upcoming FDA decision on Orladeyo for pediatric use. Community members are weighing the potential revenue from these catalysts against concerns about share dilution and overall market conditions. Some traders are eyeing specific call options, while others express frustration with the stock's historical performance relative to the biotech sector.

**What is Jesus Coin?**  Jesus Coin was launched to transform the memecoin market with a unique narrative as the only cryptocurrency that encourages generosity.  Jesus Coin is building a native transaction network on top of Ethereum to power decentralized, charitable, applications and organizations.  **What makes your project unique?**  Jesus Coin is an ERC-20 that revolutionizes generosity through open-source smart contracts and opens the door for decentralized governance within charitable organizations.  **History of your project.** Jesus Coin was conceived by [Maker Lee](https://twitter.com/0xmakerlee), after seeing a need for innovation within the non-profit world. On April 25, 2023, $JESUS conducted a fundraising sale and was the number one trending coin on [PinkSale.finance](https://pinksale.finance/) (a presale platform.) Within 24 hours, Jesus Coin attracted over 600 holders who contributed to over $2m in trading volume on [UniSwap.](https://app.uniswap.org/#/swap?outputCurrency=0xba386a4ca26b85fd057ab1ef86e3dc7bdeb5ce70)  **What’s next for your project?**  Jesus Coin is building a decentralized app to facilitate charitable giving throughout non-profit organizations and is actively looking for new partnerships in the web2 and web3 ecosystems.  **What can your token be used for?**  Jesus Coin (JESUS) can be used as a currency and as governance within the Jesus Coin network. Because the supply of JESUS is set at 777 trillion, JESUS can also be used as a store of value.

Jesus Coin

Jesus Coin ($JESUS) is trending amid discussions around its potential and recent positive momentum, with community members drawing comparisons to other meme coins and highlighting its core concept. Conversations also incorporate religious themes and biblical references, contributing to the coin's unique online presence. The community is actively discussing potential catalysts such as exchange listings and Easter.

London-based Quant Network is set to revolutionise blockchain technology with the development of their blockchain operating system Overledger. The experienced team are determined to fulfil the original vision of the internet by creating an open trusted network for people, machines, and data to operate securely and safely.  Overledger -the first interoperable blockchain operating system that facilitates internet-scale development of decentralised, multi-chain applications. Overledger has the ability to unlock and distribute value and applications across current and future blockchains. It is an agnostic platform that connects the world's networks to blockchains and ensures you're not limited to any single a vendor or technology. Overledger is the only platform that facilitates the development of internet-scales development of decentralised, multi-chain applications.

Quant

Quant is trending as the community discusses its potential role in real-world asset tokenization and interoperability between blockchains, particularly highlighting its involvement in projects like the digital euro pilot and tokenized sterling deposits. Bullish sentiment is fueled by increasing institutional adoption and the limited supply of QNT, with some traders eyeing a breakout above key resistance levels. The recent buzz is around Quant's potential to revolutionize multi-chain finance and its expanding network.

The Compound Governance Token is a governance token on the Compound Finance lending protocol, COMP allows the owner to delegate voting rights to the address of their choice; the owner’s wallet, another user, an application, or a DeFi expert. Anybody can participate in Compound governance by receiving delegation, without needing to own COMP.  Anybody with 1% of COMP delegated to their address can propose a governance action; these are simple or complex sets of actions, such as adding support for a new asset, changing an asset’s collateral factor, changing a market’s interest rate model, or changing any other parameter or variable of the protocol that the current administrator can modify.

Compound

Compound (COMP) is trending amidst mixed sentiment, with some traders anticipating a pump while others remain skeptical, citing past pump and dumps. Discussions revolve around its potential correlation with Bitcoin and Ethereum's movements, and the impact of a recent governance vote. Some community members suggest comparing COMP to AAVE.

Micron Technology, Inc. engages in the provision of innovative memory and storage solutions. It operates through the following segments: Compute and Networking Business Unit (CNBU), Mobile Business Unit (MBU), Embedded Business Unit (EBU), and Storage Business Unit (SBU). The CNBU segment includes memory products and solutions sold into client, cloud server, enterprise, graphics, and networking markets. The MBU segment is involved in memory and storage products sold into smartphone and other mobile-device markets. The EBU segment focuses on memory and storage products sold into automotive, industrial, and consumer Markets. The SBU segment consists of SSDs and component-level solutions sold into enterprise and cloud, client, and consumer storage markets. The company was founded by Ward D. Parkinson, Joseph Leon Parkinson, Dennis Wilson, and Doug Pitman on October 5, 1978 and is headquartered in Boise, ID.

Micron Technology Inc.

Micron Technology Inc

Micron Technology is trending amid optimism surrounding AI-driven demand for memory chips and recent upgrades from analysts, fueling community discussions about potential price targets. A new $9.6 billion investment in a Japan-based AI memory chip plant is adding to the positive sentiment. Despite a recent pullback, many believe the stock has significant upside potential as the memory supercycle gains momentum.

UnitedHealth Group, Inc. engages in the provision of health care coverage, software, and data consultancy services. It operates through the following segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment utilizes Optum's capabilities to help coordinate patient care, improve affordability of medical care, analyze cost trends, manage pharmacy benefits, work with care providers more effectively, and create a simpler consumer experience. The OptumHealth segment provides health and wellness care, serving the broad health care marketplace including payers, care providers, employers, government, life sciences companies, and consumers. The OptumInsight segment focuses on data and analytics, technology, and information to help major participants in the healthcare industry. The OptumRx segment offers pharmacy care services. The company was founded by Richard T. Burke in January 1977 and is headquartered in Eden Prairie, MN.

Unitedhealth Group Inc

UnitedHealth ($UNH) is trending as investors digest mixed sentiment around future earnings projections and ongoing regulatory scrutiny, particularly regarding OptumRx. The community is actively debating the potential impacts of ACA subsidies and a pending court case, while also weighing the stock's current valuation relative to competitors and broader market trends. Some traders are looking for a rotation into defensive stocks like UNH amid tech sector volatility.

Harrow, Inc. engages in the development, production, and sale of innovative medications. It operates through the following segments: Pharmaceutical Compounding and Pharmaceutical Drug Development. The Pharmaceutical Compounding segment focuses on the operations of the ImprimisRx business. The company was founded by Mark L. Baum and Robert J. Kammer on January 11, 2006 and is headquartered in Nashville, TN.

Harrow Inc

Harrow Health Inc

Harrow Health is trending as optimism builds around the company's growth strategy and potential for expansion, with community members discussing potential acquisitions and expressing excitement for the upcoming investor day. Discussions highlight the potential of VEVYE and IHEEZO, as well as upcoming launches, while some focus on technical analysis and potential price targets. Rate cut expectations and overall positive sentiment on management's execution contribute to the bullish outlook.

Workday, Inc. engages in the provision of development of enterprise cloud applications for finance and human resources. It delivers financial management, human capital management and analytics applications designed for companies, educational institutions, and government agencies. The company was founded by David A. Duffield and Aneel Bhusri in 2005 and is headquartered in Pleasanton, CA.

Workday Inc - Ordinary Shares - Class A

Workday Inc

Workday is trending following its Q3 earnings release, with community discussions focused on subscription revenue growth and AI-fueled demand; despite a clean beat, some express concern over revenue guidance and competition. The stock's price action is drawing attention, as some traders anticipate a potential bounce from oversold levels, while others highlight technical support levels and analyst rating adjustments. Community members are actively debating Workday's valuation and future growth prospects within the broader SaaS landscape.

Microsoft Corp. engages in the development and support of software, services, devices, and solutions. It operates through the following segments: Productivity and Business Processes, Intelligent Cloud, and More Personal Computing. The Productivity and Business Processes segment is composed of products and services relating to productivity, communication, and information services such as Office Commercial, Office Consumer, LinkedIn, and Dynamics business solutions. The Intelligent Cloud segment consists of public, private, and hybrid server products and cloud services for businesses and developers, as well as enterprise and partner services. The More Personal Computing segment refers to products and services including Windows operating system, Windows cloud services, Surface, HoloLens, personal computer accessories, Xbox hardware, Xbox Cloud Gaming, Microsoft News, and Microsoft Edge. The company was founded by Paul Gardner Allen and William Henry Gates, III in 1975 and is headquartered in Redmond, WA.

Microsoft Corporation

Microsoft Corp

Microsoft is trending as the community discusses its AI strategy and potential competition from Google's Gemini, impacting its market valuation. Community members are weighing the significance of Microsoft's Azure cloud and OpenAI partnership amid evolving AI infrastructure dynamics. Discussions also involve potential support levels and future price movements, with some anticipating a rebound.

MARA Holdings, Inc. is a digital asset technology company, which engages in mining cryptocurrencies with a focus on the Bitcoin ecosystem. It also deals with owning and operating bitcoin mining facilities or data centers, selling proprietary software or technology to third parties operating in the Bitcoin ecosystem, offering advisory and consulting services to support Bitcoin mining ventures in domestic and international jurisdictions, and generating electricity from renewable energy resources or methane gas capture to power Bitcoin mining projects. The company was founded on February 23, 2010 and is headquartered in Hallandale Beach, FL.

MARA Holdings Inc.

Marathon Digital Holdings Inc

Marathon Digital (MARA) is trending as traders discuss its potential for a short squeeze and its relationship to Bitcoin's price movements. Community members are debating the effectiveness of MARA's management and its ability to capitalize on the current crypto market, especially compared to its peers. Some investors are highlighting MARA's significant Bitcoin holdings and mining power, while others express concern over the company's performance and leadership.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Ekso Bionics (EKSO) Upgraded to Buy: Here's Why

Ekso Bionics (EKSO) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

Ekso Bionics (NASDAQ:EKSO) CFO Jerome Wong Sells 11,288 Shares

Ekso Bionics Holdings, Inc. (NASDAQ:EKSO - Get Free Report) CFO Jerome Wong sold 11,288 shares of the business's stock in a transaction that occurred on Monday, November 10th. The shares were sold at...

Ekso Bionics (EKSO) Reports Q3 Loss, Beats Revenue Estimates

Ekso Bionics (EKSO) delivered earnings and revenue surprises of +45.45% and +8.11%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?

Ekso Bionics (EKSO) Upgraded to Buy: Here's What You Should Know

Ekso Bionics (EKSO) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

Ekso Bionics (EKSO) May Find a Bottom Soon, Here's Why You Should Buy the Stock Now

Ekso Bionics (EKSO) appears to have found support after losing some value lately, as indicated by the formation of a hammer chart. In addition to this technical chart pattern, strong agreement among Wall Street analysts in revising earnings estimates higher enhances the stock's potential for a turnaround in the near term.

Ekso Bionics (EKSO) Reports Q2 Loss, Misses Revenue Estimates

Ekso Bionics (EKSO) delivered earnings and revenue surprises of -3.33% and -55.57%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

Retail chatter&nbsp;surrounding Ekso Bionics shares increased&nbsp;Thursday after the company revealed its acceptance into Nvidia’s Connect program.&nbsp;Ekso Bionics shares closed down 11.5% at $0.4 on Thursday but edged up 3% to $0.41 in after-hours trading.Members of the program receive access to specialized training resources, engineering support, and advanced development tools that help accelerate AI and high-performance computing projects.Ekso Bionics intends to utilize Nvidia’s resources to develop a foundational model to enhance human motion analysis in physical rehabilitation.&nbsp;The company plans to merge AI features with its exoskeleton technology, which operates within medical and industrial environments.Nvidia Connect offers technology companies exclusive participation so they can improve product development and cost efficiency through access to Nvidia GPU platforms and the global ecosystem.The stock market reacted similarly to&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/aiff-stock-soars-after-nvidia-connect-program-nod/ch5au23RuF">Firefly Neuroscience</a>, which saw its share prices increase following its acceptance into NVIDIA’s Connect program.Firefly Neuroscience intends to establish a brain function foundation model through its FDA-approved Brain Network Analytics platform.BNA utilizes artificial intelligence and machine learning to help doctors better understand brain function and deliver more precise diagnoses for neurological and mental disorders.On Stocktwits, retail sentiment for Ekso was ‘extremely bullish’ amid a 5,764% surge in 24-hour message volume.One user speculated that Ekso Bionics shares could reach $1.20, expressing a bullish outlook.&nbsp;<stembedurl>https://stocktwits.com/Guanabo498/message/614833514</stembedurl>Another user noted the downside risk appeared limited to just a few cents, arguing that the stock had already been trading at current levels.&nbsp;They said the Nvidia news, combined with a recent 13G filing, could lead to a rebound above $0.70 in premarket trading.<stembedurl>https://stocktwits.com/Deadpresidentz/message/614832229</stembedurl>The stock has declined 35.5% so far in 2025.For updates and corrections, email newsroom[at]stocktwits[dot]com.

Older version prototypes and military applications displayed at Ekso Bionics on Wednesday, June 20, 2018 in Richmond, Calif. (Photo By Liz Hafalia/The San Francisco Chronicle via Getty Images)

Ekso Bionics Ignites Bullish Retail Buzz On Nvidia Tie-Up To Boost AI-Driven Exoskeleton Solutions

The company announced its acceptance into Nvidia’s Connect program to support AI development for rehabilitation exoskeletons, triggering a 5,764% spike in retail message volume. 

Equity

Strategic Wealth Investment Group LLC Has $130,000 Stock Holdings in Ekso Bionics Holdings, Inc. (NASDAQ:EKSO)

Strategic Wealth Investment Group LLC grew its position in Ekso Bionics Holdings, Inc. (NASDAQ:EKSO  Free Report) by 21.8% in the 4th quarter, according to its most recent filing with the...

Ekso Bionics Holdings, Inc. Expected to Post Q1 2025 Earnings of ($0.09) Per Share (NASDAQ:EKSO)

Ekso Bionics Holdings, Inc. (NASDAQ:EKSO  Free Report)  Stock analysts at HC Wainwright issued their Q1 2025 earnings per share (EPS) estimates for shares of Ekso Bionics in a...

Recap: Ekso Bionics Holdings Q4 Earnings

Ekso Bionics Holdings, Inc. engages in the provision of design, development, and sale of exoskeleton technology that currently has applications in healthcare and industrial markets. The company was founded on January 30, 2012 and is headquartered in San Rafael, CA.

Ekso Bionics Holdings Inc

$AMZN

$MSFT

$GOOGL

$ORCL

Which cloud infrastructure stock offers the best long-term opportunity right now?

Fiscal Period	Estimated	Reported	Surprise	Result
Q4 '25	-$0.35	--	--	N/A
Q3 '25	-$0.96	-$0.54	44.04%	BEAT
Q2 '25	-$1.35	-$1.24	8.15%	BEAT
Q1 '25	-$0.11	-$1.80	-1536.36%	MISSED
Q4 '24	-$0.08	-$0.14	-75.00%	MISSED

EKSO
Ekso Bionics Holdings Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Upcoming Earnings: Q4 '25

Historical Earnings

Latest EKSO News

EKSOEkso Bionics Holdings Inc